1. Home
  2. BEAT vs VVOS Comparison

BEAT vs VVOS Comparison

Compare BEAT & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • VVOS
  • Stock Information
  • Founded
  • BEAT 2015
  • VVOS 2016
  • Country
  • BEAT United States
  • VVOS United States
  • Employees
  • BEAT N/A
  • VVOS N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • VVOS Medical Specialities
  • Sector
  • BEAT Technology
  • VVOS Health Care
  • Exchange
  • BEAT Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • BEAT 33.1M
  • VVOS 27.3M
  • IPO Year
  • BEAT 2021
  • VVOS 2020
  • Fundamental
  • Price
  • BEAT $1.03
  • VVOS $4.11
  • Analyst Decision
  • BEAT Buy
  • VVOS Strong Buy
  • Analyst Count
  • BEAT 1
  • VVOS 2
  • Target Price
  • BEAT $8.00
  • VVOS $6.10
  • AVG Volume (30 Days)
  • BEAT 118.9K
  • VVOS 176.0K
  • Earning Date
  • BEAT 08-13-2025
  • VVOS 08-26-2025
  • Dividend Yield
  • BEAT N/A
  • VVOS N/A
  • EPS Growth
  • BEAT N/A
  • VVOS N/A
  • EPS
  • BEAT N/A
  • VVOS N/A
  • Revenue
  • BEAT N/A
  • VVOS $14,628,000.00
  • Revenue This Year
  • BEAT N/A
  • VVOS $3.83
  • Revenue Next Year
  • BEAT N/A
  • VVOS $25.27
  • P/E Ratio
  • BEAT N/A
  • VVOS N/A
  • Revenue Growth
  • BEAT N/A
  • VVOS 9.47
  • 52 Week Low
  • BEAT $0.91
  • VVOS $1.98
  • 52 Week High
  • BEAT $3.48
  • VVOS $7.95
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 40.15
  • VVOS 41.25
  • Support Level
  • BEAT $0.91
  • VVOS $4.31
  • Resistance Level
  • BEAT $1.32
  • VVOS $4.81
  • Average True Range (ATR)
  • BEAT 0.12
  • VVOS 0.50
  • MACD
  • BEAT 0.01
  • VVOS -0.12
  • Stochastic Oscillator
  • BEAT 29.27
  • VVOS 19.68

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: